Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trial
Lisse Decraecker, Danny De Looze, David P Hirsch, Heiko De Schepper, Joris Arts, Philip Caenepeel, Albert J Bredenoord, Jeroen Kolkman, Koen Bellens, Kim Van Beek, Fedrica Pia, Willy Peetermans, Tim Vanuytsel, Alexandre Denadai-Souza, Ann Belmans, Guy Boeckxstaens
Gut Mar 2024, 73 (3) 459-469; DOI: 10.1136/gutjnl-2023-331634